Vector Science & Therapeutics Welcomes Tabitha Hendren as New Engineering Director

Vector Science & Therapeutics Appoints Tabitha Hendren as Director of Engineering and Design

On October 2, 2025, Vector Science & Therapeutics made a significant announcement with the appointment of Tabitha Hendren as its new Director of Engineering and Design. Her extensive expertise in biomedical engineering and medical device development is expected to greatly enhance the company's innovative initiatives, particularly in the realm of transdermal drug delivery.

Tabitha Hendren has an impressive background, having worked for over four years in specialized biomedical engineering roles. She holds both a Master’s degree and a Bachelor’s degree in Biomedical Engineering from the prestigious University of Michigan. Prior to this appointment, she served as a Biomedical Engineer at ZetrOZ Systems, where she played a pivotal role in leading various manufacturing operations, engaging in clinical research initiatives, and steering product development projects.

Tom Bachinski, the Chief Technology Officer at Vector Science & Therapeutics, expressed his confidence in Hendren's ability to propel the company's mission forward. "Tabitha's proven track record in medical device development, combined with her passion for improving patient outcomes and expertise in translating research into practical applications, align perfectly with our vision," he remarked. This perspective is a testament to Hendren’s capability and the anticipation surrounding her contributions.

As emphasized by CEO Bill Jackson, this strategic hire comes at a critical moment in Vector's growth. "At this pivotal stage in Vector's evolution, being engineering-led is key to our success. Tabitha brings the innovative mindset and technical excellence we need to develop cutting-edge products that meet clinical priorities and integrate seamlessly into both physicians' workflows and patients' lifestyles," he stated.

In her capacity as the Director of Engineering and Design, Hendren will oversee comprehensive engineering and design functions within the organization. This includes leading product development efforts, managing the design processes from inception to completion, and collaborating across diverse teams to cultivate innovative therapeutic solutions.

Hendren herself expressed enthusiasm about joining the Vector team. "I'm excited for the opportunity to work alongside Tom and the team at Vector to develop innovative solutions that can make a meaningful impact on patient care. The company's commitment to advanced research and therapeutic innovation presents an incredible opportunity to help introduce life-changing treatments to patients," she stated.

Founded in 2024 and based in Lodi, Wisconsin, Vector Science & Therapeutics has been at the forefront of developing novel biomechanical devices and active transdermal drug delivery systems. Their focus is on offering clinicians non-systemic, localized interventions aimed at pain management and the regeneration of musculoskeletal tissues.

As Hendren embarks on her new journey with Vector Science & Therapeutics, the potential for advancements in medical device technology is immense. Her leadership will likely enable the company to not only refine their existing products but to push the boundaries of innovation in the field, ultimately aiming to enhance patient care and improve health outcomes. This appointment signifies a proactive step towards meeting the escalating demands of the healthcare landscape, where patient-centric solutions are increasingly prioritized.

With Hendren at the helm of engineering and design, stakeholders and patients alike will be watching closely for the groundbreaking solutions that are set to emerge from Vector Science & Therapeutics in the near future.